Skip to main navigation
About Us
Company Overview
Leadership Team
Board of Directors
Our Technology
Investor Relations
IR Homepage
Press Releases
Events and Presentations
Upcoming Events
Archived Events
Presentations
Stock Information
Stock Quote/Interactive Chart
Stock prices historical lookup
Stock Calculator
Analyst Coverage
SEC Filings
Corporate Governance
Highlights
Leadership Team
Board of Directors
Committee Composition
Investor FAQ & Contacts
FAQs
Contacts
ESG Policy
Contact Us
Menu
Search
Search
About Us
Company Overview
Leadership Team
Board of Directors
Our Technology
Investor Relations
IR Homepage
Press Releases
Events and Presentations
Upcoming Events
Archived Events
Presentations
Stock Information
Stock Quote/Interactive Chart
Stock prices historical lookup
Stock Calculator
Analyst Coverage
SEC Filings
Corporate Governance
Highlights
Leadership Team
Board of Directors
Committee Composition
Investor FAQ & Contacts
FAQs
Contacts
ESG Policy
Contact Us
Breaking Boundaries
Engineering the Future Of
Targeted Medicines
Latest News
VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC
Read More
VBL Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
Read More
Copyright © 2023 VBL Therapeutics.
Terms and Conditions
.
Privacy Policy
.
Contacts
Primary IR Contact
Daniel Ferry
LifeSci Advisors
+1 (617) 430-7576
daniel@lifesciadvisors.com
Investor Tools
Print Page
RSS
Email Alerts
Contact Us